NLRP3‐Caspase‐1 Axis in Human Adipose Tissue Crown‐Like Structures: A Potential Mediator of Inflammation and the Effects of Bariatric Surgery
Immunity, Inflammation and Disease · 2026-02 · 14 (2)
DOI: 10.1002/iid3.70312 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 05.02.2026. Verfasst von Ville A Palomäki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Kuopio University Hospital, Kuopio, Finland. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Caspase 1, Inflammation, Obesity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sosiaali- ja Terveysministeriö, Ministry of Social Affairs and Health of Finland.
Abstract (Originalsprache)
Background
Obesity‐related comorbidities, such as type 2 diabetes, are associated with chronic inflammation mediated by macrophages. This inflammation is characterized by the accumulation of macrophages in crown‐like structures (CLS) surrounding dead adipocytes within adipose tissue. In a recent study, we reported a significant reduction in CLS‐associated macrophages following bariatric surgery. The NLRP3 inflammasome and its downstream effector, Caspase‐1, are well‐established mediators of metabolic dysfunction and inflammation in obesity.
Methods
Immunohistochemical single‐ and multiplex staining of subcutaneous adipose tissue (SAT) samples from patients with obesity was performed to characterize the detailed distribution of NLRP3 and Caspase‐1. The samples were collected during gastric bypass surgery and at a 1‐year follow‐up.
Results
Both NLRP3 and Caspase‐1 were expressed by CD68‐positive macrophages in SAT including both single macrophages and those forming CLS. A reduction in the total number of SAT macrophages expressing these proteins was detected following gastric bypass. Furthermore, NLRP3 and Caspse‐1 were observed in the endothelium of vascular structures.
Conclusions
Our findings demonstrate that both CLS‐forming and single cell macrophage populations in human adipose tissue express NLRP3 and Caspase‐1. The study highlights the significance of the NLRP3 inflammasome macrophages in the pathogenesis of adipose tissue inflammation in obesity. The previously reported abundance of CLS in untreated obesity and their reduction after bariatric surgery suggest that the NLRP3‐Caspase‐1 axis within CLS may serve as an important mediator of the beneficial metabolic effects associated with bariatric surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Kuopio University Hospital, Kuopio, Finland.
- Cancer and Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
- Department of Surgery, Oulu University Hospital, Oulu, Finland.
ORCID-Profile: Ville A Palomäki, Juha P Väyrynen
Förderung
- Sosiaali- ja Terveysministeriö
- Ministry of Social Affairs and Health of Finland
Zitieren
APA
Palomäki, V. A., Väyrynen, J. P., Koivukangas, V., Meriläinen, S., Karttunen, T. J., & Lehenkari, P. (2026). NLRP3‐Caspase‐1 Axis in Human Adipose Tissue Crown‐Like Structures: A Potential Mediator of Inflammation and the Effects of Bariatric Surgery. Immunity, Inflammation and Disease, 14(2). https://doi.org/10.1002/iid3.70312
Vancouver
Palomäki VA, Väyrynen JP, Koivukangas V, Meriläinen S, Karttunen TJ, Lehenkari P. NLRP3‐Caspase‐1 Axis in Human Adipose Tissue Crown‐Like Structures: A Potential Mediator of Inflammation and the Effects of Bariatric Surgery. Immunity, Inflammation and Disease. 2026;14(2). doi:10.1002/iid3.70312
BibTeX
@article{Palomki2026,
author = {Palomäki, Ville A and Väyrynen, Juha P and Koivukangas, Vesa and Meriläinen, Sanna and Karttunen, Tuomo J and Lehenkari, Petri},
title = {NLRP3‐Caspase‐1 Axis in Human Adipose Tissue Crown‐Like Structures: A Potential Mediator of Inflammation and the Effects of Bariatric Surgery},
journal = {Immunity, Inflammation and Disease},
year = {2026},
volume = {14},
number = {2},
doi = {10.1002/iid3.70312}
}
EUVIMED